UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054809
Receipt number R000062509
Scientific Title Non-invasive identification of high-risk plaques in non-culprit lesions of acute coronary syndrome
Date of disclosure of the study information 2024/06/30
Last modified on 2024/06/28 15:32:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Non-invasive identification of high-risk plaques in non-culprit lesions of acute coronary syndrome

Acronym

Non-invasive identification of high-risk plaques in non-culprit lesions of acute coronary syndrome

Scientific Title

Non-invasive identification of high-risk plaques in non-culprit lesions of acute coronary syndrome

Scientific Title:Acronym

Non-invasive identification of high-risk plaques in non-culprit lesions of acute coronary syndrome

Region

Japan


Condition

Condition

acute coronary syndrome

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objectives of the study was to determine whether delta-FFR-CT and Coronary computed tomographic angiography(CCTA) measurements could more easily differentiate lesions with maxLCBI4mm greater than 400 by near-infrared spectroscopy intravascular ultrasound (NIRS-IVUS) in non-culprit lesions of ACS.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation between maxLCBI4mm values as indicated by NIRS-IVUS and plaque density,remodeling index, presence of microcalcification and napkin ring sign as assessed by CCTA and difference between FFR-CT proximal and distal to the stenosis (delta-FFR-CT) in non-responsive lesions

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) patients were admitted with ACS (ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and unstable angina pectoris); (2) intermediate stenosis in non-culprit lesions on coronary angiography or CCTA; (3) NIRS-IVUS evaluation for intermediate stenosis after percutaneous coronary intervention; and (4) each non-culprit lesion was evaluated using CCTA and FFRCT performed within a duration of 14 days between CT and percutaneous coronary intervention.

Key exclusion criteria

(1) chronic kidney disease as shown by an estimated glomerular filtration rate <30 ml/min/1.73 m2; (2) presentation with hemodynamic instability; (3) severe valvular heart diseases, (4) left main trunk lesions; (5) lesions that could not be evaluated by NIRS-IVUS for any reason (e.g., tortuous vessels, severe stenosis, and calcification that made catheter passage difficult); and (6) poor image quality that resulted in an inability to perform CCTA or NIRS-IVUS analysis.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Masafumi
Middle name
Last name Ueno

Organization

Kindai University Faculty of Medicine

Division name

Division of Cardiology

Zip code

589-8511

Address

377-2, Ohno-Higashi, Osakasayama, Osaka, Japan

TEL

81-72-366-0221

Email

mueno@med.kindai.ac.jp


Public contact

Name of contact person

1st name Kazuyoshi
Middle name
Last name Kakehi

Organization

Kindai University Faculty of Medicine

Division name

Division of Cardiology

Zip code

589-8511

Address

377-2, Ohno-Higashi, Osakasayama, Osaka, Japan

TEL

81-72-366-0221

Homepage URL


Email

kakehi324@yahoo.co.jp


Sponsor or person

Institute

Kindai University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

Kindai University Faculty of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kindai University Faculty of Medicine

Address

377-2, Ohno-Higashi, Osakasayama, Osaka, Japan

Tel

81-72-366-0221

Email

kakehi324@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 10 Month 01 Day

Date of IRB

2021 Year 11 Month 18 Day

Anticipated trial start date

2023 Year 12 Month 01 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

After the protocol has been approved by the Director, case enrollment will begin until December 2025 (the period of accumulation may be changed depending on the status of case enrollment). The study period, including the follow-up period, will be until the end of December 2026.


Management information

Registered date

2024 Year 06 Month 28 Day

Last modified on

2024 Year 06 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062509